FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32927311000001104: Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100446001000001119 Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100446101000001118 Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has VMP Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has specific active ingredient Conjugated estrogen true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has specific active ingredient Bazedoxifene acetate true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bazedoxifene true Inferred relationship Existential restriction modifier
Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Has basis of strength substance Bazedoxifene true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Duavive 0.45mg/20mg modified-release tablets (Merck Sharp & Dohme Ltd) 28 tablet Is a True Conjugated oestrogens 450microgram / Bazedoxifene 20mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start